We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$27.1M
(-9%)
Cap. Flow
-$25.8M
Cap. Flow
% of AUM
-9.42%
Top 10 Holdings %
Top 10 Hldgs %
11.55%
Holding
791
New
365
Increased
48
Reduced
61
Closed
316
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$4.45M |
| 2 |
Marvell Technology
MRVL
|
+$3.38M |
| 3 |
CleanSpark
CLSK
|
+$2.47M |
| 4 |
Nordson
NDSN
|
+$2.29M |
| 5 |
SEE
Sealed Air
SEE
|
+$2.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$8.06M |
| 2 |
Freeport-McMoran
FCX
|
+$5.25M |
| 3 |
General Mills
GIS
|
+$3.5M |
| 4 |
Ford
F
|
+$3.44M |
| 5 |
Comcast
CMCSA
|
+$3.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.46% |
| 2 | Industrials | 15.51% |
| 3 | Healthcare | 14.71% |
| 4 | Financials | 13.15% |
| 5 | Consumer Discretionary | 12.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Core Scientific
CORZ
$6.35B
| $167K | 0.06% |
+11,497
| New | +$200K |
|
402
LSB Industries
LXU
$732M
| $167K | 0.06% |
+19,600
| New | +$173K |
|
403
Stratasys
SSYS
$764M
| $167K | 0.06% |
+19,193
| New | +$190K |
|
404
O-I Glass
OI
$1.06B
| $165K | 0.06% |
+11,176
| New | +$148K |
|
405
Akebia Therapeutics
AKBA
$236M
| $161K | 0.06% |
+100,047
| New | +$209K |
|
406
ZipRecruiter
ZIP
$407M
| $161K | 0.06% |
+41,251
| New | +$186K |
|
407
Oric Pharmaceuticals
ORIC
$1.37B
| $161K | 0.06% |
+19,638
| New | +$226K |
|
408
Ribbon Communications
RBBN
$372M
| $160K | 0.06% |
+55,568
| New | +$179K |
|
409
Anika Therapeutics
ANIK
$278M
| $160K | 0.06% |
+16,620
| New | +$159K |
|
|
CCRN
410
DELISTED
Cross Country Healthcare
CCRN
| $158K | 0.06% |
+19,504
| New | +$213K |
|
411
Evolus
EOLS
$483M
| $152K | 0.06% |
+22,919
| New | +$155K |
|
412
Riot Platforms
RIOT
$7.29B
| $149K | 0.05% |
+11,744
| New | +$201K |
|
413
Sundial Growers
SNDL
$312M
| $147K | 0.05% |
+88,749
| New | +$178K |
|
414
Wabash National
WNC
$510M
| $147K | 0.05% |
+16,998
| New | +$148K |
|
415
Novavax
NVAX
$1.29B
| $145K | 0.05% |
+21,511
| New | +$162K |
|
416
Pitney Bowes
PBI
$2.36B
| $143K | 0.05% |
+13,551
| New | +$141K |
|
417
Myriad Genetics
MYGN
$314M
| $143K | 0.05% |
+23,205
| New | +$168K |
|
418
Cleveland-Cliffs
CLF
$7.19B
| $142K | 0.05% |
+10,687
| New | +$135K |
|
419
Xperi
XPER
$335M
| $141K | 0.05% |
+24,097
| New | +$151K |
|
420
Smith & Wesson
SWBI
$633M
| $140K | 0.05% |
+14,152
| New | +$137K |
|
421
Five Point Holdings
FPH
$371M
| $139K | 0.05% |
+24,918
| New | +$147K |
|
422
FuelCell Energy
FCEL
$1.61B
| $139K | 0.05% |
+19,006
| New | +$155K |
|
423
Custom Truck One Source
CTOS
$2.42B
| $138K | 0.05% |
+23,972
| New | +$146K |
|
424
Spok Holdings
SPOK
$236M
| $137K | 0.05% |
+10,352
| New | +$147K |
|
425
Horizon Technology Finance
HRZN
$315M
| $132K | 0.05% |
20,499
-13,663
| -40% | -$87.3K |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Oxford Asset Management held 791 positions worth $274M, down 9% from $301M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Oxford Asset Management withdrew a net $25.8M in Q4 2025, closing 316 positions and reducing 61 holdings. Its most notable exit was General Mills, an estimated $3.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Oxford Asset Management opened a new position in Netflix worth $3.87M.
- Oxford Asset Management's largest Q4 2025 buy was Netflix: 41,270 shares worth $3.87M.
- Oxford Asset Management added most to Amicus Therapeutics in Q4 2025, an estimated $1.39M increase.
- Oxford Asset Management's biggest Q4 2025 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $8.06M.
- Oxford Asset Management fully exited General Mills in Q4 2025, selling an estimated $3.5M.
- Oxford Asset Management's ten largest holdings make up 12% of its $274M portfolio in Q4 2025.
- Oxford Asset Management opened 365 new positions and closed 316 in Q4 2025.
- Oxford Asset Management's portfolio value fell 9% quarter-over-quarter to $274M.
Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.